rolling circle amplification
Rarity Bioscience Building Oncology Test Portfolio on Highly Sensitive 'SuperRCA' Technology
Premium
The Swedish company is scaling up the production of targeted mutation assay kits and plans to release some of them for research use by the end of the year.
Rarity Bioscience Closes $7M Funding Round
The Swedish molecular diagnostics startup will use the funds to advance its SuperRCA cell-free and genomic DNA detection technology.
The Shenzhen-based company is hoping to penetrate the low-throughput NGS market with its sequencer, which appears to be exclusively available in China for now.
10x will develop a third genomics platform, possibly combining Cartana's more sensitive chemistry with ReadCoor's instrument.
Earlier this month, the company started accepting clinical samples at its CLIA/CAP laboratory in Pittsburgh and an affiliate laboratory in Malaysia.